Related Experiment Videos
Spatial learning impairment in aged rats: comparing between aged basal forebrain lesioned and normal aged rats
1Laboratory of Experimental Pharmacology, Suntory Ltd., Osaka, Japan.
Behavioural Brain Research
|September 1, 1995
Summary
Aged rats show learning impairments. Basal forebrain-lesioned aged rats exhibit more severe deficits, linked to reduced cholinergic and monoamine functions in specific brain regions.
Area of Science:
- Neuroscience
- Aging Research
- Cognitive Science
Background:
- Normal aging in rats leads to significant spatial learning impairments.
- Basal forebrain (BF) cholinergic system integrity is crucial for cognitive function.
Purpose of the Study:
- To investigate the impact of basal forebrain lesions on learning and neurochemical changes in aged rats.
- To compare cognitive and neurochemical profiles of normal aged rats with aged rats with BF lesions.
Main Methods:
- Morris water maze task to assess spatial learning.
- Measurement of choline acetyltransferase (ChAT) activity.
- Histological examination of cholinergic fibers (acetylcholinesterase staining).
- Quantification of vesicular acetylcholine transporter binding sites ([3H]vesamicol Bmax).
- Analysis of monoamine and metabolite levels in brain regions.
Main Results:
- Aged rats showed impaired Morris water maze performance compared to young rats.
- Aged BF-lesioned rats exhibited more severe learning deficits than normal aged rats.
- Reduced ChAT activity and cholinergic fibers in the frontal cortex of aged BF-lesioned rats.
- Altered vesicular acetylcholine transporter binding sites in aged rats.
- Markedly reduced monoamines and metabolites in the frontal cortex and striatum of aged BF-lesioned rats.
Conclusions:
- Both normal aging and BF lesions exacerbate spatial learning deficits in rats.
- Differences in learning deficits severity correlate with distinct patterns of cholinergic and monoaminergic dysfunction.
- The study highlights the critical role of the basal forebrain cholinergic system and monoaminergic pathways in age-related cognitive decline.